Articles by Kevin Coker

1. Managing Risk And Resilience In Clinical Trial Supply And Operations 2/12/2026

   Clinical leaders are shifting from reactive fixes to deliberate governance and early decision-making to sustain trial continuity under persistent operational uncertainty.

2. FDA Staffing Constraints And Operational Risk In Clinical Supply 2/11/2026

   FDA staffing shortages and supply pressures are reshaping clinical trials, requiring closer coordination across regulatory, manufacturing, and operations.

3. Tariffs Threaten Clinical Trial Supply Chains: Preparing For Volatility 2/10/2026

   Tariffs and FDA staffing gaps are quietly reshaping clinical trial supply chains. From comparators to customs delays, these forces are creating real risk for timelines, budgets, and patients.